Honoured to have received the Sinead Kinsella bursary at @IrishNephSoc. Endlessly impressed/motivated by @MaireadH92โs update at this yearโs meeting
Many thanks to attendees, presenters and funders for #INS24.
Congratulations to this yearโs award winners Sara Knezevic, Srishti Dadheech, @EAE_Elhassan@MichaelToal6@PiggottSimon ๐๐๐
1/n
๐จWelcome to #NephMadness tweetorial on Gila Monster ๐ฆ
How can @Gila_NephMad, who lives in the deserts help with the obesity epidemic?
According to @WHO, globally 1/8 persons is obese ๐
https://t.co/HWB70YHUwW
Back by popular demand, the INS is taking part in #Nephmadness 2024.
๐ Open to any nephrology department or group with an Irish connection.
๐ See below for details.
๐ Complete your bracket at https://t.co/4gnDm3Q4lK
๐ Fill out the Google form: https://t.co/U2u759tCiM
๐ We are excited to introduce the 10th NSMC internship class of 2024๐. Learn their names and follow them because they will be producing the visual abstracts, journal clubs, blog posts, tweetorials, and podcasts! These are also the future leaders of nephrology.
#NephMadness - MRA bracket. Has finerenone done what spironolactone/eplerenone couldnโt? If the Fidelio trial was recreated with spiro, would the outcomes be similar/even better?
@Stones__@Stones__ a strong bracket (biased perhaps). 2 generations of medications in the same class - study/trial design development in the 15 - 20 years between them creates a lot of discussion
๐ฎ๐ช Tertiary nephrology centre
@PiggottSimon
Jan 2020-Mar 2022
What was permcath experience?
Higher use in older population.
Most frequent reason for exchange was line sepsis followed by poor flows.
Most frequent reason for removal was renal recovery, then AVF.
#KidneyWk